68Ga-PSMA PET/CT在青少年鼻咽血管纤维瘤放疗后疗效评估中的优势
本文报道一名18岁男性青少年鼻咽血管纤维瘤患者,术后存在颅内残留病灶并接受放疗。68Ga-PSMA PET/CT仅在残留病灶处显示摄取,放疗成功应答后摄取消失,而增强MRI仍显示持续强化,提示68Ga-PSMA PET/CT可能有助于早期识别放疗应答。
要点
- 68Ga-PSMA PET/CT可区分残留肿瘤与术后改变。
- 放疗应答后PSMA摄取消失,增强MRI仍持续强化。
- PSMA PET/CT或有助于早期评估放疗应答。
核心结论
- 68Ga-PSMA PET/CT可能较常规结构成像更有利于识别青少年鼻咽血管纤维瘤放疗后的早期应答。
研究设计与样本
- 本文为个案报道,对象为一名18岁男性青少年鼻咽血管纤维瘤患者,术后存在颅内残留病灶并接受放疗。
主要发现
- 68Ga-PSMA PET/CT初始仅在残留病灶处显示摄取,放疗成功应答后该摄取消失。
- 增强MRI在放疗后仍显示持续强化。
关键数值与推荐
- PSMA在青少年鼻咽血管纤维瘤肿瘤相关新生血管内皮细胞中普遍表达。
- 功能性68Ga-PSMA PET/CT有助于将残留肿瘤与术后改变相鉴别。
临床怎么用
- 对于青少年鼻咽血管纤维瘤术后残留病灶接受放疗者,可考虑用68Ga-PSMA PET/CT辅助早期疗效评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen (PSMA) is universally expressed in the endothelial cells of tumor-associated neovasculature of juvenile nasopharyngeal angiofibroma. Functional 68Ga-PSMA PET/CT also enables easier differentiation of the residual tumor from postoperative changes. An 18-year-old man with the residual intracranial disease received radiotherapy after surgery. In PSMA PET/CT imaging, uptake was noted initially only in the residual disease, and the same was absent after successful response to radiotherapy, unlike contrast MRI, which showed persistent enhancement. Functional 68Ga-PSMA PET/CT may be a very useful tool clinically for identifying early responses to radiotherapy compared with conventional structural imaging.
引用
- Sakthivel P, Thakar A, Thankarajan Arunraj S, et al. Advantage of 68Ga-PSMA PET/CT on Postradiotherapy Response Assessment of Juvenile Nasal Angiofibroma. Clin Nucl Med. 2021. PMID: 33156054. doi:10.1097/RLU.0000000000003359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。